months(SD) ;
11 months(PR/MR) . To our opinion these unsatisfactory results are mainly due to a too late diagnosis, a heterogenous behaviour of the individual p.ca. to the drugs tested and possibly to a dose-dependency of cytostatic effectivity.That would mean,that the new tumor markers as well as pretherapeutical test models(nude mice,cell culture) might ameliorate this situation. Consequently,we started a prospective clinical study in resected patients with follow-up in short time intervals by tumor markers,sonography,CT, immunoscintigraphy and others ,and establishment of the human tumors in cell culture and nude mice to test the individual sensitivity.We also try to involve immunotherapy in this study (Mab and immunostimulants). 
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RESULTS OF SURGICAL THERAPY FOR AMPULLARY CANCER J. Meyer~ U. Sulkowski, B. lingemann, H. BOnte From 1974 to 1983 52 patients with ampullary cancer were treated at the Department of General Surgery of MOnster University. The sex ratio was 1,3:1 (29 male, 23 female patients). Ampullary eaneer secured most frequently in the age-group from 6o to 70 years. In 51 eases (98,i~) a positive histologic diagnosis could be obtained by pre-or intraoperative biopsies. Resection for cure was possible in 82,7% for the whole series and in all patients admitted during 1983 (n=io). 39 Whlpple operations and Four Total Panereatectomies were performed. Among the palliatively treated patients, three T-tubes were inserted, and twice the bile ducts were drained by a biliodigestive anastomosis. In three eases only an exploratory laparotomy was done; one patient because of general contraindications was treated endoscopieally. Usually the disease was locally limited. According to the MOnster-TNM-Olassification for pancreatic and ampullary cancer 25 patients belonged to the TiNoMo/ T2NoMo group. In-hospital-mortality was 7,7% for the Whipple operation. The main symptoms in patients with ampullary cancer were weight loss (59,6%) and jaundice (55,8%). Approximately 6o% of our patients were treated during the first three months after the onset oF symptoms. A 5-year survival rate oF 36,3% was calculated for the whole series with a median survival time of 46,2 months. 8o,7% survived the first year after the operation. In TINoMo/TZNoMo cases the 5-year survival rate amounted to 55,9%; pointing out that the Whipple operation is a curative procedure at least for limited disease. In large bowel carcinomas well differentiated tumors expressed polyclonal stemlines more often than moderately or poorly differentiated cases. In lung cancer the frequency of polyclonal DBIA stemlines was significantly higher in squarsous cell carcinomas than in the other histologic subtypes. A similar relation was not detected in ostecsarcomas.
These data indicate a high frequency of polyclonal DNA stemlines reflecting a considerable degree of genetic variability. Since polyclonal DNA stemlines probably represent secondary chromosomal aberrations which are considered to determine the biological characteristics of malignant cell populations, these data might have substantial ini0act on the prognosis and the clinical management of patients with malignant tumors. 
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